Our Mission
Our mission is to enable every person in the world to fully enjoy their vision potential.
Therefore, we develop and market innovative ophthalmic implants that mend and replace damaged tissue while mimicking its function.
In order to fulfill this vision we promote the following core values:
Innovation: Out-of-the-box thinking is our way of life. We believe in revolutionary thinking across our operations and do not adopt existing practices, systems, processes, and solutions without truly challenging them. We believe in a multi-disciplinary approach to problem solving and encourage diversified thinking.
Team: Our employees are our most valuable resource. We promote learning and personal development of our staff while making sure they all feel at home, included and united. The team will work inclusively, in cooperation, leveraging individual talent and mutual inspiration to achieve excellence.
Equality: We believe that everyone has the right to see hence will leverage our business development, distribution power, clinical operations and training activities to introduce and offer our solutions in developing and impoverished countries.
Customer Focus: Our primary customers are patients and physicians who use our products. We prioritize physician experience and ease of use. We value aesthetics and its importance to our customer base (physicians and patients) and aim to develop solutions that respect this.
Quality: We constantly invest in improving the quality of our products and processes with an aim to exceed customer expectations.
Management Team
Experienced team with a multi-disciplinary background
Scientific Advisory Board
CorNeat Vision’s Advisory Board consists of the world’s top ophthalmologists and ophthalmic innovators in cornea, glaucoma, and anterior chamber devices and surgery. Together, they have published over 650 peer reviewed papers.
Our Scientific Advisory Board consists of key opinion leaders from Israel, Canada, US, France, and China, who are planned to take an active role in our clinical trials and subsequent regulatory submissions.
